New drug duo aims to shrink tough breast cancer before surgery
NCT ID NCT07371208
Summary
This study is testing a combination of two drugs, Sac-TMT and KL-A167, as a treatment given before surgery for triple-negative breast cancer. The goal is to see if this combination can effectively shrink or eliminate the tumor and is safe for patients. The trial will enroll about 40 people with this specific type of breast cancer who have not yet had any cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Jiaotong University School of Medicine affiliated Ruijin Hospital
RECRUITINGShanghai, Shanghai Municipality, 200025, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.